4.6 Review

Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

An efficient and safe MUC1-dendritic cell-derived exosome conjugate vaccine elicits potent cellular and humoral immunity and tumor inhibition in vivo

Haomiao Zhu et al.

Summary: Antitumor vaccines that elicit antitumor immune responses and induce protective immunity against specific antigens on tumor cells are a promising strategy for preventing or treating cancers. In this study, a MUC1 glycopeptide antigen was conjugated to dendritic cell-derived exosomes (Dex) to develop an antitumor vaccine candidate. The results showed that the MUC1-Dex construct induced high levels of specific antibodies and inhibited tumor growth, prolonging survival in tumor-bearing mouse models.

ACTA BIOMATERIALIA (2022)

Review Pharmacology & Pharmacy

Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems

Hicheme Hadji et al.

Summary: The complex pathogenesis of inflammatory bowel disease (IBD) presents challenges for finding an effective cure. Current therapeutic protocols focus on reducing inflammation or maintaining remission, but drugs often have severe side effects or limited bioavailability in the inflamed regions. Researchers have explored the use of nanoparticulate drug delivery systems and polysaccharides for targeted treatment of inflamed tissues, but challenges such as high costs and primary nonresponse remain. This critical review discusses the advances in IBD treatment and reviews the use of polysaccharide nanoparticulate drug delivery systems for IBD treatment.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Review Gastroenterology & Hepatology

Review: emerging drug therapies in inflammatory bowel disease

Laurie B. Grossberg et al.

Summary: This review examines the mechanisms of action and clinical trial data of emerging drug therapies for inflammatory bowel disease (IBD). The results show that several new therapies have demonstrated positive efficacy and safety data in early clinical trials for both ulcerative colitis (UC) and Crohn's disease (CD). As more treatments for IBD are approved, further research is needed to identify predictors of response and conduct head-to-head trials to guide therapeutic options for patients.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Biochemistry & Molecular Biology

Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats

Osama Ahmed et al.

Summary: This study aimed to develop a nano-based treatment approach for ulcerative colitis by characterizing taurine-loaded chitosan pectin nanoparticles in vitro and in vivo. The administration of these nanoparticles showed beneficial effects in acetic acid-induced colitis, demonstrating anti-inflammatory and antioxidant activities, with the best therapeutic effect observed in animals treated with taurine-loaded chitosan pectin nanoparticles.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Review Pharmacology & Pharmacy

Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs

Faisal Raza et al.

Summary: This paper reviews recent advancements in gelatin-based nanomedicine for cancer therapeutics. Gelatin nanoparticles have high therapeutic potency due to their biocompatibility, biodegradability, stability, and surface properties. The paper discusses various methods for preparing gelatin nanomedicine, as well as different cross-linkers and modifications that can be used. It also evaluates drawbacks and challenges, providing important insights for the development of gelatin-based DDS for cancer therapy.

CURRENT PHARMACEUTICAL DESIGN (2022)

Article Gastroenterology & Hepatology

The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease

Christopher A. Lamb et al.

Summary: Inflammatory bowel disease exhibits significant interindividual heterogeneity, and there is a need to identify accurate methods for predicting treatment response and disease course. Precision medicine strategies offer the potential to tailor treatments to individual patient needs, but further research and international cooperation are necessary to identify and validate relevant biomarkers.

GASTROENTEROLOGY (2022)

Review Biotechnology & Applied Microbiology

Metallic Nanoparticles for the Modulation of Tumor Microenvironment; A New Horizon

Siavash Shariatzadeh et al.

Summary: Cancer, a life-threatening disease with high costs and side effects in traditional treatments, has led researchers to explore the use of metal nanoparticles for more effective and targeted therapy. Metal nanoparticles, which can easily penetrate cells and deliver drugs, show promise in photodynamic therapy and sonodynamic therapy for cancer treatment.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Article Food Science & Technology

Metallic Nanoparticles in the Food Sector: A Mini-Review

Cristina Couto et al.

Summary: Nanomaterials, particularly metallic nanoparticles, have made significant contributions to the improvement of food quality and the development of fast and sensitive monitoring devices for food assessment. The use of these nanoparticles enhances the mechanical strength of food packaging, improves gas barrier capacity, and inhibits microbial contamination, providing healthier and safer food products.

FOODS (2022)

Article Engineering, Biomedical

Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease

Neha Shrestha et al.

Summary: Nanoparticle-based oral drug delivery systems have the potential to target inflamed regions in the gastrointestinal tract. This study developed mucus-penetrating nanoparticles to encapsulate monoclonal antibodies for the treatment of inflammatory bowel disease. The results showed that the length of the PEG chain had a significant impact on the efficacy of the nanoparticles in vivo.

ACTA BIOMATERIALIA (2022)

Review Cell Biology

Regulatory role of short-chain fatty acids in inflammatory bowel disease

Zhilin Zhang et al.

Summary: This article discusses the association between inflammatory bowel disease (IBD) and dysbiosis of the gut microbiota, which leads to persistent immune response and inflammation. Short-chain fatty acids (SCFAs) derived from fiber-rich diet produced by probiotic gut bacteria have shown anti-inflammatory effects and can delay the progression of IBD. The modulation of innate immune recognition and cytokine production by SCFAs may intervene in the progression of IBD. More studies are needed to investigate the clinical impact of SCFA.

CELL COMMUNICATION AND SIGNALING (2022)

Review Pharmacology & Pharmacy

Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions

Nanxi Chen et al.

Summary: This article introduces the extraction, construction strategies, and therapeutic effects of plant-derived exosome-like NPs (PDENs) in various diseases. It also discusses the future direction and challenges of this technology.

EXPERT OPINION ON DRUG DELIVERY (2022)

Review Biochemistry & Molecular Biology

Interactions between Nanoparticles and Intestine

Manuela Vitulo et al.

Summary: This article introduces the application of nanoparticles in the oral administration route, including the functionalization of nanoparticles drug carriers, nanoparticles for local treatment in the intestine, and potential concerns and side effects of nanoparticles used as food additives.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Chemistry, Multidisciplinary

Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment

Chi-Pin James Wang et al.

Summary: Inflammatory bowel diseases (IBDs) are gastrointestinal inflammatory disorders featuring chronic intestinal inflammation. Novel biomaterial-based platforms have been developed to deliver drugs to damaged sites with increased efficacy and reduced side effects in IBD treatments.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Nanoscience & Nanotechnology

pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis

Haiting Xu et al.

Summary: An oral nanoparticle encapsulated in chitosan/alginate hydrogel with pH and reactive oxygen species sensitivity was developed for targeted delivery of curcumin. The nanoparticles showed ideal particle size and high encapsulating efficiency, and exhibited significant anti-inflammatory effects against ulcerative colitis in mice.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2022)

Review Pharmacology & Pharmacy

Plant-derived exosome-like nanoparticles and their therapeutic activities

Jisu Kim et al.

Summary: Nanotechnologies have been successfully applied in the treatment of various diseases. Plant-derived exosome-like nanoparticles (PENs) are expected to be effective therapeutic modalities, minimizing cytotoxicity to healthy tissues while targeting tumors with specific endocytosis mechanisms. This review summarizes the features and bioactivities of PENs extracted from grape, grapefruit, ginger, lemon, and broccoli, and discusses their applications as therapeutics and nanocarriers.

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Article Multidisciplinary Sciences

Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease

Qichen Shen et al.

Summary: This review discusses the modulatory functions of extracellular vesicles (EVs) in the intestine, with a focus on their roles and applications in the clinical therapy of inflammatory bowel disease (IBD). By establishing EV-mediated interaction systems between host intestine and microbiota, the possible mechanisms of IBD pathogenesis and its cure are described.

JOURNAL OF ADVANCED RESEARCH (2022)

Review Pediatrics

New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease

Qi-Qi Li et al.

Summary: Very early onset inflammatory bowel disease (VEO-IBD) is characterized by multifactorial chronic recurrent intestinal inflammation. Recent studies found that genetic and immunologic abnormalities are closely related to VEO-IBD.

FRONTIERS IN PEDIATRICS (2022)

Review Pharmacology & Pharmacy

Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer

Ying Cai et al.

Summary: Inflammatory bowel disease (IBD) is a chronic recurrent intestinal disease with limited treatment options and potential side effects of conventional drugs. It is also associated with colitis-associated cancer (CAC). Plant-derived exosomes have been found to be able to target drug delivery to the intestine, showing great potential for the treatment of intestinal diseases.

PHARMACEUTICS (2022)

Review Gastroenterology & Hepatology

Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

Ashwin N. Ananthakrishnan et al.

Summary: Environmental and lifestyle factors are crucial in the development of Crohn's disease and ulcerative colitis. A group of international experts have provided a series of consensus statements for the management of inflammatory bowel disease (IBD), including recommendations on smoking cessation, mental health screening, regular physical activity, and evidence-based dietary approaches.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

The Intestinal Barrier-Shielding the Body from Nano- and Microparticles in Our Diet

Marlene Schwarzfischer et al.

Summary: Nano- and microparticles are present in human diet, but their impact on human health is not fully understood. This review focuses on the effects of titanium dioxide (TiO2) and plastic particles ingested through food on epithelial integrity, gut homeostasis, and intestinal inflammation, which are currently hot topics of research attracting public attention.

METABOLITES (2022)

Review Gastroenterology & Hepatology

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?

Sang Hyoung Park

Summary: Inflammatory bowel disease (IBD) is a global disease, and there are regional disparities in Asia. Understanding the epidemiology of IBD in Asian countries is crucial for adequate healthcare systems.

INTESTINAL RESEARCH (2022)

Review Chemistry, Applied

Advances in the colon-targeted chitosan based multiunit drug delivery systems for the treatment of inflammatory bowel disease

Nilesh Kulkarni et al.

Summary: Chitosan, a cationic polymer with biodegradability, is a suitable choice for colon-targeted drug delivery in inflammatory bowel disease. Its ability to attach strongly to mucosa and interact with anionic polymers enables safe and efficient delivery to the colon. Compared to commercial grade gastro-resistant polymers, chitosan is considered safer for long-term therapy in chronic diseases.

CARBOHYDRATE POLYMERS (2022)

Review Agriculture, Dairy & Animal Science

Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation

Muhammad Akhtar et al.

Summary: This review summarizes the role of short chain fatty acids (SCFA) in modulating gut inflammation and highlights their potential and applications in the treatment of inflammatory bowel disease (IBD).

ANIMAL NUTRITION (2022)

Article Engineering, Biomedical

Manipulate intestinal organoids with niobium carbide nanosheets

Brittney Reding et al.

Summary: This study investigates the effects of niobium carbide (Nb2C) nanosheets on intestinal cells by placing them in intestinal organoids mimicking the real functions of an intestinal system. Results suggest that an optimal concentration of nanosheets can stimulate intestinal cells without toxic effects, while high concentrations inhibit growth. Organoids with nanosheets exhibit more viability and stimulation under infrared exposure compared to control organoids.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2021)

Article Nanoscience & Nanotechnology

Antioxidant Enzymes Sequestered within Lipid-Polymer Hybrid Nanoparticles for the Local Treatment of Inflammatory Bowel Disease

Zhicheng Le et al.

Summary: This study developed safe and efficient local drug delivery systems for treating inflammatory bowel disease by encapsulating SOD in lipid-polymer hybrid nanoparticles, which exhibited good enzymatic stability and activity. The nanoparticles with PEG coating and folate functionalization showed excellent mucu-penetrating ability and inflammation-targeting properties, enhancing mucosal retention time and drug delivery efficiency within the colorectal region. The findings suggest that antioxidant enzymes sequestered within lipid-polymer hybrid nanoparticles could be potential enzyme therapeutics for local treatment of inflammatory diseases in the future.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Engineering, Biomedical

'Green' nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases

Menghang Zu et al.

Summary: This study presents a natural nanotherapeutic derived from tea leaves, which possess desirable particle sizes and negative surface charge, and contain a wealth of lipids, functional proteins, and bioactive small molecules. The nanotherapeutics can specifically internalize in macrophages via galactose groups on the surface, showing anti-inflammatory effects and promoting gut microbiota diversity.

BIOMATERIALS (2021)

Review Chemistry, Applied

Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review

Mingxiao Cui et al.

Summary: Polysaccharide-based nanocarriers can help reduce the side effects of drugs used for treating inflammatory bowel disease (IBD) by targeting the colon and enhancing their bioavailability. Polysaccharides also play a role in alleviating IBD through their anti-inflammatory and intestinal microecological regulatory effects.

CARBOHYDRATE POLYMERS (2021)

Article Chemistry, Applied

Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease

Xin Li et al.

Summary: The study developed an oral delivery system using nano-in-microparticles loaded with Infliximab, which can target inflamed intestine, alleviate colitis, and maintain the intestinal epithelial barrier.

CARBOHYDRATE POLYMERS (2021)

Review Biochemistry & Molecular Biology

Antimicrobial Resistance and Inorganic Nanoparticles

Andrea-Sarahi Balderrama-Gonzalez et al.

Summary: Antibiotics are becoming less effective, leading to higher mortality rates and increased health recovery costs for patients with infections. Antimicrobial resistance is considered a global health problem, prompting research into the mechanisms involved. Nanotechnology plays a key role in addressing antimicrobial resistance, with nanomaterials acting as carriers to improve drug potency and overcome antibiotic barriers in bacteria.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Strawberry-Derived Exosome-Like Nanoparticles Prevent Oxidative Stress in Human Mesenchymal Stromal Cells

Francesca Perut et al.

Summary: EPDENs isolated from strawberries have been shown to have potential health-promoting activities, including preventing oxidative stress in human mesenchymal stromal cells. The presence of vitamin C in the EPDEN membrane may contribute to this effect, along with the small RNAs and miRNAs found in the cargo. These findings suggest that Fragaria-derived EPDENs may serve as nanoshuttles in food with bioactive properties.

BIOMOLECULES (2021)

Article Cell Biology

M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation

Jiaxi Lu et al.

Summary: Abnormal immune regulation is a key feature of the pathogenic mechanism of ulcerative colitis, with macrophages and ILC2s playing important roles, particularly in decreased E-cadherin expression. The study found that increased miR-21a-5p expression in peritoneal exosomes correlates negatively with E-cadherin expression, and that miR-21a-5p is derived mainly from M1 macrophages, with KLRG1 promoting excessive ILC2 activation in UC. These findings provide molecular targets and a theoretical basis for understanding and improving the treatment of UC.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Materials Science, Biomaterials

Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis

Anas Ahmad et al.

Summary: The study formulated Eudragit-S100 coated 5-ASA-loaded gelatin nanoparticles for localized delivery in ulcerative colitis treatment. The nanoparticles showed superior therapeutic efficacy over free 5-ASA by reducing disease activity, restoring colonic mucosa, and decreasing inflammatory biomarkers levels.

MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)

Review Biotechnology & Applied Microbiology

Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment

Huailan Wang et al.

Summary: Nanobiotechnology plays a crucial role in drug delivery, with various nanoparticles showing new properties that may benefit clinical treatment. Nanoparticle-mediated drug delivery systems are being utilized in anti-inflammatory therapies to efficiently deliver drugs and improve therapeutic outcomes in diseases affected by inflammation. The review discusses nanoparticles with potential anti-inflammatory activity and offers insights into the future application of nanomedicine in inflammatory diseases.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Review Biotechnology & Applied Microbiology

How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions

Piotr Eder et al.

Summary: Despite significant advancements in the treatment of inflammatory bowel disease in recent years, there is still a large room for improvement. Oral anti-TNF-alpha antibody therapy is hypothesized to provide targeted anti-inflammatory effects without significant systemic exposure, potentially improving long-term treatment outcomes and safety. Various attempts have been made to design oral formulations of these molecules, aiming to enter a new era of treatment for IBD.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Pharmacology & Pharmacy

Metallic nanoparticles as drug delivery system for the treatment of cancer

Neha Desai et al.

Summary: Metallic nanoparticles show promise in cancer therapy by targeting tumor cells through mechanistic pathways, offering high specificity and efficiency. Recent advancements in nanotechnology highlight their potential for more effective cancer treatment.

EXPERT OPINION ON DRUG DELIVERY (2021)

Review Pharmacology & Pharmacy

Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease

Xiaomei Wang et al.

Summary: Inflammatory bowel disease (IBD) is a type of chronic relapsing inflammatory disease with unclear pathogenesis involving environmental factors, genetic factors, intestinal microbiota disorder, and abnormal immune responses. Exosomes, with sizes ranging from 30-150 nm, are involved in IBD pathogenesis by mediating intercellular communication and regulating cell activity through non-coding RNAs, proteins, and lipids. Understanding the roles of exosomes in IBD may offer new diagnostic markers and therapeutic targets.

PHARMACEUTICS (2021)

Article Materials Science, Biomaterials

Melatonin-loaded chitosan nanoparticles endows nitric oxide synthase 2 mediated anti-inflammatory activity in inflammatory bowel disease model

Jignesh Mohanbhai Soni et al.

Summary: Inflammatory Bowel Disease (IBD) is a complex inflammatory condition caused by interactions of environmental and genetic factors, requiring potent anti-inflammatory drugs for treatment. Melatonin-loaded chitosan nanoparticles show promising anti-inflammatory effects, effectively reducing inflammatory markers and improving disease symptoms.

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)

Article Microbiology

Metal Nanoparticles as Novel Antifungal Agents for Sustainable Agriculture: Current Advances and Future Directions

Aida R. Cruz-Luna et al.

Summary: The use of metal nanoparticles has been shown to be an effective alternative for controlling phytopathogenic fungi in agriculture. Various metal nanoparticles, such as Ag and Cu, have demonstrated strong antifungal activities. Different synthesis methods producing nanoparticles with diverse shapes and sizes have shown outstanding results in controlling phytopathogenic fungi.

JOURNAL OF FUNGI (2021)

Review Nanoscience & Nanotechnology

Metallic-nanoparticle release systems for biomedical implant surfaces: effectiveness and safety

Marcel F. Kunrath et al.

Summary: Bioengineering for implant devices currently focuses on developing functionalized surfaces, bioactive coatings, and metallic nanoparticles for controlled drug release to reduce infection rates and improve clinical outcomes. However, concerns regarding negative effects such as cytotoxicity and bioaccumulation of nanoparticles have also emerged, necessitating further investigation.

NANOTOXICOLOGY (2021)

Review Chemistry, Analytical

Exosomes as Powerful Engines in Cancer: Isolation, Characterization and Detection Techniques

Marwa Gamal Saad et al.

Summary: Exosomes are powerful extracellular nanovesicles released from living cells, serving as communication engines that control and reprogram physiological pathways. They are biomarkers for diseases and have potential in cancer treatment. Research on exosomes aims to relate biomarkers to origins and evaluate technologies for therapeutic purposes.

BIOSENSORS-BASEL (2021)

Review Pharmacology & Pharmacy

Oral delivery of proteins and peptides: Challenges, status quo and future perspectives

Quangang Zhu et al.

Summary: Oral administration of proteins and peptides has been a big demand in clinical use, and research has focused on developing new technologies to overcome GI barriers, such as enteric coating, enzyme inhibitors, permeation enhancers, nanoparticles, and intestinal microdevices. Some new technologies have been under clinical trials or even on the market.

ACTA PHARMACEUTICA SINICA B (2021)

Review Pharmacology & Pharmacy

Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases

Menghang Zu et al.

Summary: The incidence of inflammatory bowel disease (IBD) is increasing worldwide, and natural active small molecules (NASMs) have shown potential in preventing and alleviating IBD. With the development of nanotechnology, polymeric nanoparticles (NPs) offer a promising platform to encapsulate versatile NASMs, enhancing their stability and bioavailability for targeted delivery to tissues or cells in IBD treatment.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Biochemistry & Molecular Biology

Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease

Angela Saez et al.

Summary: Inflammatory bowel disease (IBD) is a complex condition involving chronic intestinal inflammation and is associated with genetics, environment, immune system, and intestinal barrier function. Recent studies have shown that innate lymphoid cells (ILCs) play crucial roles in intestinal homeostasis and IBD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Nanoscience & Nanotechnology

Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease

Fengqian Chen et al.

Summary: Inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis are highly debilitating due to the imbalance of inflammatory mediators within the inflamed bowel. Conventional drugs for IBD treatment suffer from bioavailability issues and systemic side effects, while nanoparticle (NP)-derived therapy has shown improvements in therapeutic efficacy and targeting specificity. Recent studies have highlighted the fast-growing field of nanomedicines tailored to the pathophysiology of bowel diseases, offering potential for prolonged circulation period and reduced side effects through improved drug encapsulation and targeted delivery.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Article Pharmacology & Pharmacy

A ROS-responsive fluorescent probe detecting experimental colitis by functional polymeric nanoparticles

Yanbing Wang et al.

Summary: Oxidative stress is crucial in the pathogenesis of inflammatory bowel disease, and the TotalROX probe combined with an oral nanoparticle delivery system can effectively detect the degree of colitis. Experimental results show that TotalROX nanoparticles have the potential to image cells effectively.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Pharmacology & Pharmacy

Colon-targeted delivery of tacrolimus using pH-responsive polymeric nanoparticles for murine colitis therapy

Xiaoran Cai et al.

Summary: The study successfully developed an oral nanoparticle delivery system for the effective treatment of inflammatory bowel disease by preparing FK506/HP-β-CD inclusion compounds and adsorbing ES100 and HA onto the nanoparticles loaded with FK506/HP-β-CD through electrostatic interactions. FK506@EHCh NPs displayed promising results in suppressing inflammation and showed potential for targeted treatment of inflammatory bowel disease.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Review Chemistry, Multidisciplinary

Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives

Aline Martins dos Santos et al.

Summary: Colon-targeted oral drug delivery is a promising approach for treating intestinal diseases, though it faces challenges that require advanced strategies and the use of micro- and nanoparticles for localized therapy. Polysaccharides-based nano-in-microparticulate systems have key properties and advantages for effective colon-specific oral delivery, showing potential for targeted therapy within the colon.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Food Science & Technology

Plant-derived exosome-like nanoparticles: A concise review on its extraction methods, content, bioactivities, and potential as functional food ingredient

Sigit Suharta et al.

Summary: Plant-derived exosome-like nanoparticles (PDENs) are small vesicles released by multivesicular bodies to regulate immunity and gene expression. They have potential health benefits and can be extracted from plant materials using various techniques. However, their potency as a functional food ingredient requires further research due to sensitivity to storage and processing conditions.

JOURNAL OF FOOD SCIENCE (2021)

Article Polymer Science

5-Aminosalicylic Acid Loaded Chitosan-Carrageenan Hydrogel Beads with Potential Application for the Treatment of Inflammatory Bowel Disease

Cristina Elena Stavarache et al.

Summary: The aim of this study was to prepare mucoadhesive particles using biopolymers and 5-aminosalicylic acid for controlled drug release at the colon level, with potential applications in the treatment of intestinal bowel disease. The particles were prepared through crosslinking of chitosan with sodium tripolyphosphate and the influence of k-carrageenan layer was studied. Encapsulation efficiency and drug release profile of 5ASA were assessed using UV-VIS spectrometry, while chemical characterization was done using FT-IR spectrometry. The results suggest that these particle systems could be a versatile platform for targeted drug delivery in inflammatory bowel disease treatment.

POLYMERS (2021)

Review Pharmacology & Pharmacy

The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting

Meng Sun et al.

Summary: Inorganic nanomaterials are increasingly utilized in EGFR-mediated therapy to address limitations and enhance the efficacy of molecular targeted cancer treatment. Their ease of preparation, modification, and biosecurity make them promising candidates for cancer treatment research aimed at improving EGFR-targeted therapy.

FRONTIERS IN PHARMACOLOGY (2021)

Review Chemistry, Multidisciplinary

Drug Targeting of Inflammatory Bowel Diseases by Biomolecules

Joana Costa Antunes et al.

Summary: Inflammatory bowel disease (IBD) is a group of chronic, incurable immune-mediated inflammatory diseases including Crohn's disease and ulcerative colitis. Current treatments are limited in efficacy and come with risks of serious side effects and other complications, necessitating the need for effective treatment options. The gut microbiota's role in maintaining health may increase susceptibility to IBD development.

NANOMATERIALS (2021)

Article Immunology

Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress

Mahira Zeeshan et al.

Summary: The study demonstrated that glycyrrhizic acid-loaded polylactic-co-glycolic acid (GA-PLGA) nanoparticles have significant protective and therapeutic effects against 5-FU-induced intestinal mucositis.

INFLAMMOPHARMACOLOGY (2021)

Article Infectious Diseases

Enzyme-Responsive Nanoparticles and Coatings Made from Alginate/Peptide Ciprofloxacin Conjugates as Drug Release System

Yannick Bourgat et al.

Summary: The controlled release of antibacterial agents through nanogels has been shown to be effective in managing peri-implant infections. However, the efficacy of the released drug may be hindered by residual linkers. The feasibility of enzyme-triggered drug release has been successfully demonstrated.

ANTIBIOTICS-BASEL (2021)

Article Chemistry, Multidisciplinary

A biomimetic nanocomposite made of a ginger-derived exosome and an inorganic framework for high-performance delivery of oral antibodies

Yuling Mao et al.

Summary: This study introduces a novel biomimetic nanocomposite for colon-targeted delivery of anti-TNF-alpha antibodies through the oral route, utilizing ginger-derived exosomes and an inorganic framework. The nanocomposite showed stability, colonic targeting, and high efficacy in inflammatory bowel disease therapy.

NANOSCALE (2021)

Review Chemistry, Multidisciplinary

Soft materials as biological and artificial membranes

Shukun Tang et al.

Summary: This review discusses the emergence of soft materials in synthetic biology, with a focus on biological and artificial membranes. It highlights the construction of non-native membranes and polymeric membranes for medical applications, as well as the preparation of artificial membranes using synthetic materials. By modifying artificial membranes through traditional chemical methods, such as click reactions, targeted delivery of nanocarriers and controlled release of therapeutics can be achieved. Biological membranes with active domains play a crucial role in disease targeting and inspire the development of nanocarriers with artificial membranes for complex diseases.

CHEMICAL SOCIETY REVIEWS (2021)

Review Chemistry, Medicinal

Advances in colon-targeted nano-drug delivery systems: challenges and solutions

Muhammad Naeem et al.

ARCHIVES OF PHARMACAL RESEARCH (2020)

Review Biochemistry & Molecular Biology

The Integral Role of Tight Junction Proteins in the Repair of Injured Intestinal Epithelium

Zachary M. Slifer et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Multidisciplinary Sciences

The biology, function, and biomedical applications of exosomes

Raghu Kalluri et al.

SCIENCE (2020)

Article Gastroenterology & Hepatology

Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels

Mohammad Tauqeer Alam et al.

GUT PATHOGENS (2020)

Review Biochemistry & Molecular Biology

Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review

Xuqian Lang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Article Gastroenterology & Hepatology

Mucus barrier, mucins and gut microbiota: the expected slimy partners?

Paola Paone et al.

Review Medicine, General & Internal

Pathophysiology of Inflammatory Bowel Diseases

John T. Chang

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Nanoscience & Nanotechnology

Techniques and Applications of Animal- and Plant-Derived Exosome-Based Drug Delivery System

Fulong Man et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2020)

Review Chemistry, Multidisciplinary

Implications of the Human Gut-Brain and Gut-Cancer Axes for Future Nanomedicine

Ibrahim Javed et al.

ACS NANO (2020)

Review Pharmacology & Pharmacy

Nanoparticles: Oral Delivery for Protein and Peptide Drugs

Shu-jun Cao et al.

AAPS PHARMSCITECH (2019)

Article Medicine, General & Internal

Mucus and mucins in diseases of the intestinal and respiratory tracts

G. C. Hansson

JOURNAL OF INTERNAL MEDICINE (2019)

Review Nanoscience & Nanotechnology

Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives

Chunhua Yang et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)

Article Biochemistry & Molecular Biology

Microbial network disturbances in relapsing refractory Crohn's disease

Bahtiyar Yilmaz et al.

NATURE MEDICINE (2019)

Article Microbiology

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Eric A. Franzosa et al.

NATURE MICROBIOLOGY (2019)

Article Engineering, Biomedical

Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases

Zahra Davoudi et al.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2018)

Article Biotechnology & Applied Microbiology

Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease

Gurpreet Kaur Sinhmar et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)

Article Biotechnology & Applied Microbiology

Promising therapeutic effect of gold nanoparticles against dinitrobenzene sulfonic acid-induced colitis in rats

Rehab M. Hussein et al.

NANOMEDICINE (2018)

Article Chemistry, Medicinal

Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis

Hong Zhou et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2018)

Review Pharmacology & Pharmacy

A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets

Yasamin Davatgaran Taghipour et al.

DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

Article Biochemistry & Molecular Biology

Synthesis and evaluation of anti-inflammatory properties of silver nanoparticle suspensions in experimental colitis in mice

Krzysztof Siczek et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2017)

Article Nanoscience & Nanotechnology

In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles

Yan Ru Wu et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Article Biotechnology & Applied Microbiology

Broccoli-Derived Nanoparticle Inhibits Mouse Colitis by Activating Dendritic Cell AMP-Activated Protein Kinase

Zhongbin Deng et al.

MOLECULAR THERAPY (2017)

Article Biotechnology & Applied Microbiology

Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa

Leticia Herminia Higa et al.

NANOMEDICINE (2017)

Review Nanoscience & Nanotechnology

Discrimination between ulcerative colitis and Crohn's disease using phage display identified peptides and virus-mimicking synthetic nanoparticles

Sonia Facchin et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)

Article Gastroenterology & Hepatology

Solid lipid nanoparticles delivering anti- inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model

Chiara Dianzani et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

The intestinal barrier: a fundamental role in health and disease

Maaike Vancamelbeke et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Chemistry, Multidisciplinary

Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease

Lina Herrera Estrada et al.

ACS NANO (2017)

Review Biophysics

Recent applications of PLGA based nanostructures in drug delivery

Maria Mir et al.

COLLOIDS AND SURFACES B-BIOINTERFACES (2017)

Review Multidisciplinary Sciences

Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation

Vicky Garcia-Hernandez et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)

Review Immunology

Dysbiosis and the immune system

Maayan Levy et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Pharmacology & Pharmacy

Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases

John Youshia et al.

EXPERT OPINION ON DRUG DELIVERY (2016)

Review Microbiology

Gut biogeography of the bacterial microbiota

Gregory P. Donaldson et al.

NATURE REVIEWS MICROBIOLOGY (2016)

Review Pathology

Genetics and Pathogenesis of Inflammatory Bowel Disease

Ta-Chiang Liu et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

Review Biochemistry & Molecular Biology

Communication by Extracellular Vesicles: Where We Are and Where We Need to Go

Mercedes Tkach et al.

Article Pharmacology & Pharmacy

Effect of particle size on their accumulation in an inflammatory lesion in a dextran sulfate sodium (DSS)-induced colitis model

Ayaka Watanabe et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)

Article Chemistry, Multidisciplinary

Role of nanoparticle size, shape and surface chemistry in oral drug delivery

Amrita Banerjee et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Review Pharmacology & Pharmacy

Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery

Lin Zhang et al.

JOURNAL OF DRUG TARGETING (2016)

Review Oncology

Targeting folate receptor alpha for cancer treatment

Anthony Cheung et al.

ONCOTARGET (2016)

Review Medicine, Research & Experimental

Poly(amido amine) dendrimers in oral delivery

Venkata K. Yellepeddi et al.

TISSUE BARRIERS (2016)

Review Pharmacology & Pharmacy

Non-genetic engineering of cells for drug delivery and cell-based therapy

Qun Wang et al.

ADVANCED DRUG DELIVERY REVIEWS (2015)

Review Pharmacology & Pharmacy

Polymeric nanoparticle drug delivery technologies for oral delivery applications

Eric M. Pridgen et al.

EXPERT OPINION ON DRUG DELIVERY (2015)

Article Medicine, Research & Experimental

Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair

Giovanna Leoni et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Chemistry, Medicinal

Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System

Mirko Koziolek et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2015)

Article Medicine, Research & Experimental

Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue

Dallin Hubbard et al.

MOLECULAR PHARMACEUTICS (2015)

Article Chemistry, Multidisciplinary

An intestinal Trojan horse for gene delivery

Haisheng Peng et al.

NANOSCALE (2015)

Review Nutrition & Dietetics

Gut Microbiome: What We Do and Don't Know

Gail A. Cresci et al.

NUTRITION IN CLINICAL PRACTICE (2015)

Review Gastroenterology & Hepatology

Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases

Sung Hee Lee

INTESTINAL RESEARCH (2015)

Review Biochemistry & Molecular Biology

Drug targeting using solid lipid nanoparticles

Elham Rostami et al.

CHEMISTRY AND PHYSICS OF LIPIDS (2014)

Article Biophysics

Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon

Muhammad Naeem et al.

COLLOIDS AND SURFACES B-BIOINTERFACES (2014)

Article Pharmacology & Pharmacy

Design, synthesis and in vitro evaluation of mucoadhesive p-coumarate-thiolated-chitosan as a hydrophobic drug carriers

Thatthai Pengpong et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)

Review Pharmacology & Pharmacy

Advances in oral macromolecular drug delivery

Seung Rim Hwang et al.

EXPERT OPINION ON DRUG DELIVERY (2014)

Article Chemistry, Medicinal

pH-Sensitive Nanoparticles of Curcumin-Celecoxib Combination: Evaluating Drug Synergy in Ulcerative Colitis Model

Dalapathi Gugulothu et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2014)

Article Biotechnology & Applied Microbiology

Targeted Drug Delivery to Intestinal Macrophages by Bioactive Nanovesicles Released from Grapefruit

Baomei Wang et al.

MOLECULAR THERAPY (2014)

Article Pediatrics

Stool Microbiota and Vaccine Responses of Infants

M. Nazmul Huda et al.

PEDIATRICS (2014)

Article Gastroenterology & Hepatology

Enteric glial cells and their role in the intestinal epithelial barrier

Yan-Bo Yu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Intestinal barrier in inflammatory bowel disease

Lena Antoni et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Materials Science, Biomaterials

Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticles

Bo Xiao et al.

JOURNAL OF MATERIALS CHEMISTRY B (2014)

Article Pharmacology & Pharmacy

Eudragit (R): a technology evaluation

Seema Thakral et al.

EXPERT OPINION ON DRUG DELIVERY (2013)

Review Nanoscience & Nanotechnology

Application of liposomes in drug development - focus on gastroenterological targets

Jian-Xin Zhang et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)

Article Pharmacology & Pharmacy

Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis

Ana Beloqui et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)

Article Pharmacology & Pharmacy

Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies

Regis Coco et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)

Article Biotechnology & Applied Microbiology

Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis

Songwen Ju et al.

MOLECULAR THERAPY (2013)

Review Pharmacology & Pharmacy

Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery

S. Sadekar et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Review Pharmacology & Pharmacy

Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease

Bo Xiao et al.

EXPERT OPINION ON DRUG DELIVERY (2012)

Article Gastroenterology & Hepatology

An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice

Long Binh Vong et al.

GASTROENTEROLOGY (2012)

Review Chemistry, Multidisciplinary

Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa

Eva-Maria Collnot et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Article Chemistry, Multidisciplinary

Nanoparticle-based clodronate delivery mitigates murine experimental colitis

Wiebke Niebel et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Review Pharmacology & Pharmacy

Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery

Surajit Das et al.

AAPS PHARMSCITECH (2011)

Article Gastroenterology & Hepatology

Nanoparticle-based Therapeutic Delivery of Prohibitin to the Colonic Epithelial Cells Ameliorates Acute Murine Colitis

Arianne L. Theiss et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Medicine, Research & Experimental

CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice

Hang Thi Thu Nguyen et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Biotechnology & Applied Microbiology

Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine

Jung Soo Suk et al.

NANOMEDICINE (2011)

Article Chemistry, Multidisciplinary

PAMAM Dendrimers for siRNA Delivery: Computational and Experimental Insights

Giovanni Maria Pavan et al.

CHEMISTRY-A EUROPEAN JOURNAL (2010)

Review Pharmacology & Pharmacy

Drug delivery using multifunctional dendrimers and hyperbranched polymers

Constantinos M. Paleos et al.

EXPERT OPINION ON DRUG DELIVERY (2010)

Article Biotechnology & Applied Microbiology

Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice

Selvaraj BarathManiKanth et al.

JOURNAL OF NANOBIOTECHNOLOGY (2010)

Article Chemistry, Medicinal

Further Evidence of the Anti-inflammatory Effects of Silver Nanoparticles

Kenneth K. Y. Wong et al.

CHEMMEDCHEM (2009)

Review Pharmacology & Pharmacy

Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System

S. Mukherjee et al.

INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)

Editorial Material Chemistry, Multidisciplinary

In quest of a systematic framework for unifying and defining nanoscience

Donald A. Tomalia

JOURNAL OF NANOPARTICLE RESEARCH (2009)

Article Medicine, Research & Experimental

Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic Mucosa

Boaz Tirosh et al.

MOLECULAR PHARMACEUTICS (2009)

Article Chemistry, Medicinal

Lipid Nanoparticles with a Solid Matrix (SLN, NLC, LDC) for Oral Drug Delivery

Marc Muchow et al.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)

Review Gastroenterology & Hepatology

Microbial influences in inflammatory bowel diseases

R. Balfour Sartor

GASTROENTEROLOGY (2008)

Review Pharmacology & Pharmacy

Gut instincts: Explorations in intestinal physiology and drug delivery

Emma L. McConnell et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)

Article Chemistry, Medicinal

Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system

Weilun Ke et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2008)

Editorial Material Multidisciplinary Sciences

Therapeutic correction of bacterial dysbiosis discovered by molecular techniques

R. Balfour Sartor

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Gastroenterology & Hepatology

Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis

Kailash C. Bhol et al.

DIGESTIVE DISEASES AND SCIENCES (2007)

Article Biochemistry & Molecular Biology

Prohibitin protects against oxidative stress in intestinal epithelial cells

Arianne L. Theiss et al.

FASEB JOURNAL (2007)

Article Pharmacology & Pharmacy

Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats

A Lamprecht et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Chemistry, Multidisciplinary

Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes

TT Jubeh et al.

PHARMACEUTICAL RESEARCH (2004)

Review Biotechnology & Applied Microbiology

Challenges for the oral delivery of macromolecules

M Goldberg et al.

NATURE REVIEWS DRUG DISCOVERY (2003)

Article Chemistry, Multidisciplinary

Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid

R Wiwattanapatapee et al.

JOURNAL OF CONTROLLED RELEASE (2003)

Article Pharmacology & Pharmacy

Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis

KJ Myers et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Review Biochemistry & Molecular Biology

The mannose receptor family

L East et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)

Article Pharmacology & Pharmacy

New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease

H Nakase et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)

Article Chemistry, Multidisciplinary

Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa

A Lamprecht et al.

PHARMACEUTICAL RESEARCH (2001)